[64Cu]CuCl2 as a Novel Metabolic Marker of Progression and Survival in Muscle-Invasive Bladder Cancer[64Cu]CuCl2作为肌肉浸润性膀胱癌进展和生存的新型代谢标志物Molecular Imaging and BiologyIF2.52026-09-020OAAI
Diagnostic and Dosimetry Features of [64Cu]CuCl2 in High-Grade Paediatric Infiltrative GliomasMOLECULAR IMAGING AND BIOLOGYIF2.52022-08-308PRE
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatmentEUROPEAN JOURNAL OF CANCERIF7.12021-12-0132OAAI
Head-to-head comparison among 18F-choline PET/CT, 4D contrast-enhanced CT, and 18F-choline PET/4D contrast-enhanced CT in the detection of hyperfunctioning parathyroid glands: a systematic review and meta-analysisENDOCRINEIF2.92021-06-2519PREAI
Head-to-head comparison between 18F-DOPA PET/CT and 68Ga-DOTA-peptide PET/CT in detecting intestinal neuroendocrine tumours: A systematic review and meta-analysisCLINICAL ENDOCRINOLOGYIF2.42021-06-1924OAAI
How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and genderEuropean Journal of Nuclear Medicine and Molecular ImagingIF7.62020-09-2112PREAI
Indeterminate thyroid nodules. The role of 18F-FDG PET/CT in the era of ultrasonography risk stratification systems and new thyroid cytology classificationsENDOCRINEIF2.92020-03-0227PREAI
Diagnosis, Treatment Response, and Prognosis: The Role of 18F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with 123I-mIBG Scan: The First Prospective StudyJOURNAL OF NUCLEAR MEDICINEIF9.12019-09-2037OAAI
Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implicationsEJNMMI RESEARCHIF32018-03-0132OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向